TMCnet News
Research and Markets: Global Gastro-oesophageal Reflux Drug Pipeline Capsule - 2012 UpdateNov 12, 2012 (M2 PRESSWIRE via COMTEX) -- Research and Markets (http://www.researchandmarkets.com/research/5rkt5c/global) has announced the addition of the "Global Gastro-oesophageal Reflux Drug Pipeline Capsule - 2012 Update" report to their offering. Fore Pharma's latest report 'Global Gastro-oesophageal Reflux Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Gastro-oesophageal Reflux market. It covers active Gastro-oesophageal Reflux pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery. This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals. The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report. Key Topics Covered: 1. Gastro-oesophageal Reflux - Disease Overview 2. Gastro-oesophageal Reflux Pipeline Overview 3. Gastro-oesophageal Reflux Phase 3 Clinical Trial Pipeline Insights 4. Gastro-oesophageal Reflux Phase 2 Clinical Trial Pipeline Insights 5. Gastro-oesophageal Reflux Phase 1 Clinical Trial Pipeline Insights 6. Gastro-oesophageal Reflux Preclinical Research Pipeline Insights 7. Gastro-oesophageal Reflux Discovery Stage Pipeline Insights 8. Gastro-oesophageal Reflux Drug Development Activities - Geographic Landscape 8.1. Gastro-oesophageal Reflux R&D Activities in North America 8.2. Gastro-oesophageal Reflux R&D Activities in Europe 9. Gastro-oesophageal Reflux Pipeline - Licensing Activities Table 1. Gastro-oesophageal Reflux Pipeline Molecules - Phase 3 Clinical Trial Table 2. Gastro-oesophageal Reflux Pipeline Molecules - Phase 2 Clinical Trial Table 3. Gastro-oesophageal Reflux Pipeline Molecules - Phase 1 Clinical Trial Table 4. Gastro-oesophageal Reflux Pipeline Molecules - Preclinical Research Table 5. Gastro-oesophageal Reflux Pipeline Molecules - Drug Discovery Table 6. Gastro-oesophageal Reflux R&D Activities by Geography Table 7. Gastro-oesophageal Reflux Pipeline Molecules - North America Table 8. Gastro-oesophageal Reflux Pipeline Molecules - Europe Table 9. Gastro-oesophageal Reflux Pipeline - Licensing Activities Figure 1. Gastro-oesophageal Reflux Pipeline Molecules by R&D Stage Figure 2. Gastro-oesophageal Reflux R&D Activities by Geography For more information visit http://www.researchandmarkets.com/research/5rkt5c/global CONTACT: Research and Markets, Laura Wood, Senior Manager. [email protected] Fax from USA: 646-607-1907 Fax from rest of the world: +353-1-481-1716 Sector: Pharmaceuticals (http://www.researchandmarkets.com/categories.asp cat_id=16&campaign_id=5rkt5c) ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected]. |